SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

India Rating reaffirms rating of Claris Lifesciences’ bank facilities

20 Mar 2015 Evaluate

Credit rating agency, India Rating & Research (Ind- Ra) has affirmed ‘A’ rating with a ‘Stable’ outlook to long term bank facilities to Claris Lifesciences. Since all the working capital and term loans have been transferred to Claris Injectables (CIL), the agency has withdrawn the ratings of the short term / long term loan instruments of CLL. However the same ratings have been assigned to CIL instruments.

Claris Lifesciences is one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.

 

Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×